Updates in the pharmacotherapeutic management of familial hypercholesterolemia (FH): present and emerging treatment options

Cost: Free

View Offer chevron_right

Details

Familial hypercholesterolemia (FH), also known as type II hyperlipoproteinemia, is an autosomal dominant disorder characterized by elevated plasma LDL-C levels in the absence of hypertriglyceridemia (or if triglycerides are elevated, they are so independently of FH).

After completing Updates in the pharmacotherapeutic management of familial hypercholesterolemia (FH): present and emerging treatment options physicians will better be able to:

  • Describe the pathophysiology and genetics of FH such that they might inform treatment mechanisms
  • Describe presently available and emerging treatment options for FH and apply them to patient cases
  • Evaluate a FH treatment plan and suggest modifications for improvement
  • Describe clinical and logistical challenges associated with treating and educating patients with FH

 

Target Audience: Cardiology and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in cardiology; and any other clinicians with an interest in FH.

Stay up-to-date

Receive special offers, keep up with MOC requirements and stay informed of the latest offerings in free online CME in your specialty.